Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

23,646 signal articles · 311 in last 24h · 112,568 total before filter · latest 1h ago

311last 24h

2076last 7d

366● bullish (7d)

180● bearish (7d)

204publishers

All Macro307 Earnings1153 M&A89 Regulatory23 Product14 Analyst20

✕ clear all filtersticker: LLYsentiment: neutralSentiment:bullish neutral bearish show all (incl. clickbait)

MarketBeat103d agoneutral

Eli Lilly and Company Q1 Earnings Call Highlights

Eli Lilly and Company (NYSE:LLY) executives said the drugmaker started 2026 with “a strong start,” pointing to sharp first-quarter revenue growth, continued demand for its incretin medicines, a newly approved oral obesity therapy, and a slate of pipeline and business development milestones. Founday

LLY